Our Services
Medical Information
Helpful Resources
Published on: 7/21/2026
Black women starting GLP-1 injections should consider a baseline DEXA scan to measure bone density before major weight loss begins. This is especially important for those with risk factors such as early menopause, a family history of osteoporosis, or long-term steroid use. Rapid weight loss can accelerate bone density decline, making early assessment critical for prevention.
Key steps include:
Because bone health risks vary widely from person to person, understanding your individual profile is the smartest first step before starting or continuing GLP-1 therapy. A quick, private evaluation of your symptoms and risk factors can help you decide whether to pursue a DEXA scan, adjust your nutrition, or speak with a specialist. Take a free, instant, online symptom check now to clarify your next steps and protect your long-term bone health.
Reviewed for medical accuracy: 07/21/2026
GLP-1 agonists (often called "GLP-1s," e.g. semaglutide, liraglutide) have become popular for type 2 diabetes and weight management. As more patients consider these injections, questions arise about potential effects on bone health—especially in Black women, who traditionally have higher bone density but still face unique risks. Below, we review what the research tells us about GLP-1 and bone density scans, and help you decide whether a DEXA scan makes sense before you start therapy.
GLP-1 agonists work by:
Weight loss is common—sometimes 5–15% of body weight in a few months. However, rapid or significant weight loss can lead to bone-mineral loss. In the general population, studies have shown:
Key point: GLP-1s may indirectly affect bones through weight loss, appetite changes, or hormonal shifts.
Black women on average have:
That said, they still face osteoporosis and fracture risk, particularly after menopause or with other risk factors. Reasons to consider bone density evaluation include:
While Black women start with a "bone density advantage," age and weight-loss therapies can change that picture.
A DEXA scan (dual-energy X-ray absorptiometry) measures bone mineral density at the hip and spine. It gives you a T-score (compared to young adults) and a Z-score (age-matched). Guidelines (e.g., by the National Osteoporosis Foundation) recommend screening:
If you're a Black woman planning GLP-1 therapy, think about a DEXA scan if you have:
Even if you don't meet formal criteria, a baseline DEXA can be a helpful reference. It lets your provider track changes over time if you lose a lot of weight on GLP-1 therapy.
Whether or not you do a DEXA first, you can support bone strength:
Nutrition
Exercise
Lifestyle
Monitoring
Assess Your Risk
Discuss With Your Doctor
Optimize Bone Health
Monitor Over Time
If you're considering GLP-1 therapy, it's wise to get a clear picture of your bone health before you start. Before your appointment, you can use a Medically approved LLM Symptom Checker Chat Bot to organize your symptoms and health concerns, helping you have a more focused, productive conversation with your doctor.
Important: This information is for educational purposes and does not replace medical advice. Always speak to a doctor about any serious symptoms or life-threatening issues. If you have chest pain, severe shortness of breath, sudden limb weakness, or other urgent concerns, seek immediate medical care.
Bottom Line
For many Black women, a baseline DEXA scan before starting GLP-1 injections can be a smart precaution—especially if you plan to lose significant weight or have other osteoporosis risk factors. Work closely with your healthcare provider to create a personalized plan for bone health, monitoring, and lifestyle support.
(References)
* Sáez-López, C., et al. (2022). "GLP-1 Receptor Agonists and Bone Health: A Systematic Review and Meta-Analysis." *Calcified Tissue International*, 110(3), 302-315.
* Rao, S. D., et al. (2023). "Weight Loss and Bone Health in Type 2 Diabetes: A Systematic Review." *Journal of the Endocrine Society*, 7(3), bvac193.
* Looker, H. C., et al. (2010). "Bone mineral density in African Americans: a systematic review." *Journal of the National Medical Association*, 102(2), 118-124.
* Lee, S. J., et al. (2013). "Racial and ethnic disparities in the diagnosis and treatment of osteoporosis." *Current Osteoporosis Reports*, 11(2), 105-112.
* Varela, J. E., et al. (2016). "Bone mineral density changes after bariatric surgery: a systematic review and meta-analysis." *Obesity Surgery*, 26(10), 2530-2544.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.